Home/HAGAR/Dr. Gerry Vaintrub
DG

Dr. Gerry Vaintrub

CTO

HAGAR

Therapeutic Areas

HAGAR Pipeline

DrugIndicationPhase
GWaveDiabetes mellitus (continuous glucose monitoring)Phase 2